Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nitric Oxide Treatment In COVID-19 Evaluation

Next Previous
Trial Profile

Nitric Oxide Treatment In COVID-19 Evaluation

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Nov 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications COVID-19 respiratory infection
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms NOTICE

    • Most Recent Events

    • 20 Nov 2020 New trial record
    • 10 Nov 2020 According to a Mallinckrodt plc media release, the company will partner with Pharmerit - an OPEN Health company - to collect data from approximately 200 hospitalized adult patients with a confirmed diagnosis of COVID-19 who were treated with INOmax for pulmonary complications associated with COVID-19 for at least 24 hours between January 1, 2020 and July 31, 2020. Patient data will be reviewed for the period from hospital admission to 30 days post-discharge.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top